A new generation of artificial intelligence is starting to read the human genome with a fluency that would have sounded like ...

It could transform our understanding of why diseases develop and the medicines needed to treat them, says researchers.

Fixing gene defects with designer DNA is on the horizon after Google DeepMind launched a pioneering new AI tool.

Only approximately 2 per cent of the human genome encodes proteins, the rest being left to serve as an elaborate control system- one that harbors much of the variants associated with common disease.

Google’s artificial intelligence research laboratory where AlphaFold was developed—has officially released a new machine ...

Model predicts effect of mutations on sequences up to 1 million base pairs in length and is adept at tackling complex ...

Artificial intelligence has gotten a bad reputation lately, and often for good reason. But a team of scientists at Google’s ...

Researchers have revealed that so-called ‘junk DNA’ contains powerful switches that help control brain cells linked to Alzheimer’s disease. When people picture DNA, they often imagine a set of genes ...

There are some genes that can promote cancer; they are sometimes called oncogenes, and in tumor cells, mutations are often found in these genes. When they are functioning normally, oncogenes are often ...

Scientists have found that non-coding 'junk' DNA, far from being harmless and inert, could potentially contribute to the development of cancer. Their study has shown how non-coding DNA can get in the ...

Researchers reckon it could dramatically accelerate understanding of how DNA influences disease, cancer, and drug discovery.